In a first-of-its-kind experiment tracing evolution across 25 generations, scientists have discovered that marine ...

What if a heart attack and lifetime of statin drugs could be avoided with a one-time, two-hour infusion? Kiran Musunuru, a University of Pennsylvania cardiologist and leading gene-editing researcher, ...

The growing incidence of infectious diseases, cancer, and chronic illnesses has substantially increased the demand for cutting-edge mRNA-based therapies. The surge in mRNA vaccine adoption, especially ...

Fact check: HHS misleads on mRNA vaccine safety after pulling Moderna funding The safety of approved mRNA vaccines is well-established and, as with other vaccines, continues to be monitored by ...

The BioNTech SE acquisition of CureVac N.V. brings together complementary technologies, as both are developing mRNA candidates. Click for my look at BNTX and CVAC.

In the quest to design vaccines that better help the body's immune system fight disease, scientists are always looking for more tools for their arsenal.

Researchers have developed a new mRNA vaccine that overcomes the challenges associated with current mRNA therapeutic technology.

Trump HHS ends nearly $1 billion in funding to Moderna for mRNA bird flu vaccines, citing safety concerns and lack of oversight around the new mRNA vaccine technology.

About Strand Therapeutics Strand Therapeutics is a clinical-stage biotechnology company developing programmable mRNA therapeutics to transform the treatment of cancer and other serious diseases.

About Strand Therapeutics Strand Therapeutics is a next-generation biotechnology company committed to transforming the lives of patients by developing first-in-class programmable mRNA therapeutics.